Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (141-150 of 412) with videos related to

Pageof 42
Sort By:
Archives of Pathology & Laboratory Medicine|April 17, 2026
Temperature-Dependent Long-term and Short-term Stability of Human Epidermal Growth Factor 2 Antigenicity on Pathology SlidesLiam Scott, Julia Benanto, Charles J Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2017
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating LymphocytesMehmet Altan, Vasiliki Pelekanou, Kurt A Schalper, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcomeSummar F Siddiqui, John Pawelek, Tamara Handerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non-Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial ProfilingJon Zugazagoitia, Swati Gupta, Yuting Liu, et al.
JCO Precision Oncology|September 14, 2020
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast CancersTess O'Meara, Michal Marczyk, Tao Qing, et al.
Breast Cancer Research and Treatment|February 15, 2011
Differential expression of arrestins is a predictor of breast cancer progression and survivalAllison M Michal, Amy R Peck, Thai H Tran, et al.
Molecular and Cellular Biology|July 13, 2011
A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transitionSanjeev Kumar, Sun Hee Park, Benjamin Cieply, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 15, 2019
A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung CancerClive R Taylor, Anagha P Jadhav, Abhi Gholap, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2013
Automated objective determination of percentage of malignant nuclei for mutation testingHollis Viray, Madeline Coulter, Kevin Li, et al.
Journal for Immunotherapy of Cancer|March 10, 2019
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, et al.
Pageof 42

Showing results (141-150 of 412) with videos related to

Sort By:
Pageof 42
Archives of Pathology & Laboratory Medicine|April 17, 2026
Temperature-Dependent Long-term and Short-term Stability of Human Epidermal Growth Factor 2 Antigenicity on Pathology SlidesLiam Scott, Julia Benanto, Charles J Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2017
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating LymphocytesMehmet Altan, Vasiliki Pelekanou, Kurt A Schalper, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcomeSummar F Siddiqui, John Pawelek, Tamara Handerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non-Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial ProfilingJon Zugazagoitia, Swati Gupta, Yuting Liu, et al.
JCO Precision Oncology|September 14, 2020
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast CancersTess O'Meara, Michal Marczyk, Tao Qing, et al.
Breast Cancer Research and Treatment|February 15, 2011
Differential expression of arrestins is a predictor of breast cancer progression and survivalAllison M Michal, Amy R Peck, Thai H Tran, et al.
Molecular and Cellular Biology|July 13, 2011
A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transitionSanjeev Kumar, Sun Hee Park, Benjamin Cieply, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 15, 2019
A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung CancerClive R Taylor, Anagha P Jadhav, Abhi Gholap, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2013
Automated objective determination of percentage of malignant nuclei for mutation testingHollis Viray, Madeline Coulter, Kevin Li, et al.
Journal for Immunotherapy of Cancer|March 10, 2019
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, et al.
Pageof 42